Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing
Here is the plain-English version
History of cancer requires careful consideration given the growth-promoting properties of these peptides, though no evidence suggests they promote tumor growth in normal tissue
use within approximately 30 days [7]
Status checked July 30, 2026 Regulatory status can change
.
US$ 23.30
US$ 24.71
US$ 27.52
US$ 24.41
US$ 22.64
US$ 29.91
US$ 20.40
US$ 22.85
US$ 29.19
